Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02208011
Other study ID # L8608-W13010
Secondary ID
Status Completed
Phase
First received
Last updated
Start date August 2014
Est. completion date June 2015

Study information

Verified date August 2020
Source Louisiana State University, Baton Rouge
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Specific objectives include analysis of performance of ROM Plus® in diagnosing ROM, as compared to Amnisure® and the conventional clinical assessment confirmed by a thorough chart review after delivery.

Inclusion Criteria:

- English speaking

- pregnant woman >15 weeks gestation undergoing an exam for ruptured membranes

Exclusion Criteria:

- Known placental previa

- Active vaginal bleeding


Recruitment information / eligibility

Status Completed
Enrollment 140
Est. completion date June 2015
Est. primary completion date June 2015
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria:

- complaint of ruptured membranes

- IUP > 15 weeks gestation

- English speaking, over the age of 18yrs old

Exclusion Criteria:

- active bleeding

- placenta previa

Study Design


Related Conditions & MeSH terms

  • Evidence of Ruptured Membranes in Women Greater Than 15 Weekd
  • Rupture

Locations

Country Name City State
United States Woman's Hospital Baton Rouge Louisiana

Sponsors (4)

Lead Sponsor Collaborator
Louisiana State University, Baton Rouge Clinical Innovations, LLC, Louisiana State University Health Sciences Center in New Orleans, Woman's Hospital, Louisiana

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary evidence of ruptured membranes up to delivery of infant